KEYBANK NATIONAL ASSOCIATION/OH - SANGAMO THERAPEUTICS INC ownership

SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 215 filers reported holding SANGAMO THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 1.04 and the average weighting 0.1%.

Quarter-by-quarter ownership
KEYBANK NATIONAL ASSOCIATION/OH ownership history of SANGAMO THERAPEUTICS INC
ValueSharesWeighting
Q3 2018$570,000
+2.9%
33,614
-13.9%
0.00%0.0%
Q2 2018$554,000
+16.1%
39,033
+55.4%
0.00%0.0%
Q1 2018$477,000
-23.1%
25,112
-33.6%
0.00%
-25.0%
Q4 2017$620,000
-0.5%
37,809
-9.0%
0.00%0.0%
Q3 2017$623,000
-16.8%
41,527
-51.2%
0.00%0.0%
Q2 2017$749,000
+6.5%
85,157
-37.0%
0.00%0.0%
Q1 2017$703,000
+70.2%
135,2470.0%0.00%
+33.3%
Q4 2016$413,000
-5.5%
135,247
+43.3%
0.00%0.0%
Q3 2016$437,000
-7.0%
94,393
+16.2%
0.00%0.0%
Q2 2016$470,000
+7.8%
81,245
+12.8%
0.00%0.0%
Q1 2016$436,000
-28.3%
72,030
+8.2%
0.00%
-25.0%
Q4 2015$608,000
+71.8%
66,565
+6.2%
0.00%
+33.3%
Q3 2015$354,000
-16.1%
62,684
+64.6%
0.00%0.0%
Q2 2015$422,000
+4.7%
38,086
+48.2%
0.00%0.0%
Q1 2015$403,000
-3.8%
25,692
-6.6%
0.00%0.0%
Q4 2014$419,000
+54.0%
27,518
+8.9%
0.00%
+50.0%
Q3 2014$272,000
-40.1%
25,258
-15.0%
0.00%
-33.3%
Q2 2014$454,000
-11.2%
29,701
+5.1%
0.00%
-25.0%
Q1 2014$511,000
+3.9%
28,265
-20.2%
0.00%
+33.3%
Q4 2013$492,000
+50.0%
35,434
+13.3%
0.00%
+50.0%
Q3 2013$328,000
+23.3%
31,266
-8.3%
0.00%
+100.0%
Q2 2013$266,000
+21.5%
34,101
+48.7%
0.00%0.0%
Q1 2013$219,000
+10.1%
22,937
-30.6%
0.00%0.0%
Q4 2012$199,00033,0400.00%
Other shareholders
SANGAMO THERAPEUTICS INC shareholders Q2 2018
NameSharesValueWeighting ↓
Golden State Equity Partners 154,360$897,0000.45%
Rhenman & Partners Asset Management AB 761,429$4,424,0000.44%
Lombard Odier Asset Management (Switzerland) SA 860,702$5,001,0000.39%
WASATCH ADVISORS LP 10,576,997$61,452,0000.30%
Rokos Capital Management LLP 977,663$5,861,0000.27%
KLK CAPITAL MANAGEMENT LLC 44,323$258,0000.26%
Long Focus Capital Management, LLC 340,000$1,975,0000.25%
Vanguard Capital Wealth Advisors 33,380$193,0000.14%
Fort Sheridan Advisors LLC 73,978$430,0000.13%
Delphia (USA) Inc. 20,983$122,0000.09%
View complete list of SANGAMO THERAPEUTICS INC shareholders